NCT01707368

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Course of Psoriasis During Long Term Treatment With Calcipotriol Plus Betamethasone in Gel Formulation

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 561 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this observational study is to document the course of disease and relapse management during treatment with Daivobet® Gel under consideration of patient's individual application habits under daily use conditions.

Conditions

• Psoriasis Vulgaris
• Plaque Psoriasis

Interventions

Type	Name	Description
DRUG	Daivobet® Gel	Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance.

Timeline

• Start date: 2012-10-01
• Primary completion: 2014-05-01
• Completion: 2014-07-01
• First posted: 2012-10-16
• Last updated: 2018-09-24
• Results posted: 2018-09-24

Locations

1 site across 1 country: Germany